1. Home
  2. JVA vs NCEL Comparison

JVA vs NCEL Comparison

Compare JVA & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

SELL

Current Price

$4.63

Market Cap

26.4M

ML Signal

SELL

Logo NewcelX Ltd. Ordinary Shares

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.90

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JVA
NCEL
Founded
1971
2008
Country
United States
Switzerland
Employees
92
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.4M
19.4M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
JVA
NCEL
Price
$4.63
$2.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 76.6K
4.3K
Earning Date
09-11-2026
10-23-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.68
N/A
Revenue
★ $90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.81
★ N/A
Revenue Growth
★ 17.54
N/A
52 Week Low
$2.93
$1.83
52 Week High
$5.03
$5.12

Technical Indicators

Market Signals
Indicator
JVA
NCEL
Relative Strength Index (RSI) 67.92 41.94
Support Level $4.15 $2.73
Resistance Level $4.59 $3.18
Average True Range (ATR) 0.18 0.17
MACD 0.05 0.02
Stochastic Oscillator 79.16 29.65

Price Performance

Historical Comparison
JVA
NCEL

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: